NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,072 filers reported holding NOVARTIS A G in Q3 2021. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $189,969 | +6.2% | 1,865 | +5.2% | 0.02% | 0.0% |
Q2 2023 | $178,813 | +2.6% | 1,772 | -6.5% | 0.02% | -3.8% |
Q1 2023 | $174,340 | +1.4% | 1,895 | 0.0% | 0.03% | -3.7% |
Q4 2022 | $171,914 | +16.9% | 1,895 | -2.1% | 0.03% | +12.5% |
Q3 2022 | $147,000 | -10.4% | 1,935 | 0.0% | 0.02% | -7.7% |
Q2 2022 | $164,000 | -3.5% | 1,935 | 0.0% | 0.03% | +13.0% |
Q1 2022 | $170,000 | +6.9% | 1,935 | +6.7% | 0.02% | +15.0% |
Q4 2021 | $159,000 | +7.4% | 1,813 | 0.0% | 0.02% | 0.0% |
Q3 2021 | $148,000 | -10.3% | 1,813 | 0.0% | 0.02% | -9.1% |
Q2 2021 | $165,000 | +11.5% | 1,813 | +4.5% | 0.02% | 0.0% |
Q1 2021 | $148,000 | -23.3% | 1,735 | -15.3% | 0.02% | -29.0% |
Q4 2020 | $193,000 | +2.1% | 2,049 | -6.0% | 0.03% | -13.9% |
Q3 2020 | $189,000 | -19.6% | 2,179 | -19.2% | 0.04% | -28.0% |
Q2 2020 | $235,000 | +8.8% | 2,696 | +3.0% | 0.05% | -13.8% |
Q1 2020 | $216,000 | -12.6% | 2,618 | +0.5% | 0.06% | +1.8% |
Q4 2019 | $247,000 | – | 2,604 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |